Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations.
about
Subcutaneous Administration of Bortezomib: A Pilot Survey of Oncology NursesBiocompatible materials for continuous glucose monitoring devicesForum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015Implantable batteryless device for on-demand and pulsatile insulin administrationAn open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjectsIdentification and comparison of insulin pharmacokinetics injected with a new 4-mm needle vs 6- and 8-mm needles accounting for endogenous insulin and C-peptide secretion kinetics in non-diabetic adult males.The appropriateness of the length of insulin needles based on determination of skin and subcutaneous fat thickness in the abdomen and upper arm in patients with type 2 diabetes.Indian Injection Technique Study: Population Characteristics and Injection PracticesComment on the New Indian Injection Technique Recommendations: Critical Appraisal of the Real-World Implementation of the Current Guidelines.Forum for Injection Technique and Therapy Expert Recommendations, India: The Indian Recommendations for Best Practice in Insulin Injection Technique, 2017.Subcutaneous administration of bortezomib: strategies to reduce injection site reactions.Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.A patient care program for adjusting the autoinjector needle depth according to subcutaneous tissue thickness in patients with multiple sclerosis receiving subcutaneous injections of glatiramer acetate.Subcutaneous Injection Depth Does Not Affect the Pharmacokinetics or Glucodynamics of Insulin Lispro in Normal Weight or Healthy Obese Subjects.Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wearAnalysis and perspective: comparison of insulin diluent leakage post-injection using two different needle lengths and injection volumes in obese patients with type 1 or type 2 diabetes mellitus.Mechanistic determinants of biotherapeutics absorption following SC administration.Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study.Forum for injection techniques, India: the first Indian recommendations for best practice in insulin injection techniqueRandomized trial of infusion set function: steel versus teflon.Effects of age, gender, BMI, and anatomical site on skin thickness in children and adults with diabetes.Efficacy of a Novel Prefilled, Single-Use, Needle-Free Device (Zeneo®) in Achieving Intramuscular Agent Delivery: An Observational Study.Biomechanics of the sensor-tissue interface-effects of motion, pressure, and design on sensor performance and the foreign body response-part I: theoretical framework.Insulin administration: selecting the appropriate needle and individualizing the injection technique.Translating the research in insulin injection technique: implications for practice.Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusionPractice tips and tools for the successful use of U-500 regular human insulin: the diabetes educator is key.Improving Medication Dosing in the Obese Patient.Perforation of fragment simulating projectiles into goat skin and muscle.Nontraditional Considerations With Insulin Needle Length SelectionPharmacokinetics of Monoclonal Antibodies.Tissue Variability and Antennas for Power Transfer to Wireless Implantable Medical Devices.Lipohypertrophy and the artificial pancreas: is this an issue?Access site-related complications after transradial catheterization can be reduced with smaller sheath size and statins.Subcutaneous adipose tissue thickness in adults - correlation with BMI and recommendations for pen needle lengths for subcutaneous self-injection.Optimizing insulin injection technique and its effect on blood glucose control.Case report: increased patient response to intramuscular haloperidol decanoate following a change in needle length.Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a.Breakage of growth hormone needle in subcutaneous tissue.Ultrasound-guided measurement of skin and subcutaneous tissue thickness in children with diabetes and recommendations for giving insulin injections.
P2860
Q26771947-A0E8407A-DA37-468D-B598-A71615E3B562Q26823654-3D08DCB9-4956-49CC-98D4-8CCB46CAE436Q28082186-36D7C0EE-6828-4E86-A03C-DC5D54ACEFA9Q30846603-F73C3E84-7EEB-4E93-A2ED-B3B1A10A41CCQ31038370-598C5422-A1EF-47EA-B0E3-E048D4E88027Q33588892-B676E258-510E-4DD0-8290-DA901E185821Q33612508-0ADEECC2-20C4-4FDA-B689-E2161F9338C4Q33732565-DA582091-7BA3-409A-85F5-E7F2D7142CCCQ33732634-E11C0126-D859-4A63-A600-A3C4C06B0CDFQ33815567-91FCA739-3540-4BE0-B133-D0CE7CC7594BQ33885696-3B434999-4816-4473-9923-B8B2817A5785Q35056512-6BEF25FB-678E-42BB-99DB-45C28B45E8D3Q35100874-953BB580-C282-41DE-B58F-3ADBFAF14BE0Q35918417-2E1ACC35-475D-454D-9BF3-AFA08D6F5D8CQ35929406-CDE3EE88-C03C-46AC-B0CF-5EA901AF0FA0Q36051307-E3A2CF45-5F02-41F1-9134-3ACA5923AF2FQ36065572-0FE12A6E-B27E-404B-97DE-A96847083554Q36340429-7FAD2C52-BD8A-4382-BBD7-3B957C9C7259Q36436481-49374B4A-5F09-4223-9008-529BABE3FDECQ37460135-C188A06D-ECDF-4D8B-B304-9531C1ECE940Q37500543-523A2DDD-3DD1-47EE-A01C-3D875CD9D1E9Q37562449-925C5F2E-CF60-47CD-BB4B-B935E82D1A49Q37896743-5E38A759-98B1-4E4D-B36F-A119B0AD59D3Q37921796-CB9D0C52-77D7-4D89-9738-C2AF6F19D692Q38034911-F1710FE1-F4DC-4557-8D85-9BF9C3C50182Q38037730-FB23A826-5C70-49D5-A9DF-D5F845DE134BQ38155486-4767F89C-A3E9-49D8-AA26-F34B401D28C3Q38947388-BA5FFE0C-8235-4650-A68B-1B2C14C4D486Q39410746-CB84E5D0-30FD-4479-AD3F-FD8EA1E040D2Q42070175-B5062976-7028-4F90-B02A-156A9C096514Q42118646-5E92FECC-8D04-4CD6-9F15-6C9A31732544Q42275794-17A4BF4E-8082-4063-807F-85E3831C6C1BQ42724240-311788D7-9170-4706-A4DA-D6DD7E989AA5Q43447905-516B6C81-AE43-4D70-959E-BD1DE42FA153Q43477736-FEFC02F8-6272-4D57-A731-9ACAE322B83AQ45913310-863B48A0-D173-485D-9CFC-3E572E96DC9AQ46622663-994A5DC4-8E60-440E-A420-EE7A725F4921Q48064606-5A92A604-4D8E-4118-B0BD-4D1C6DDB2C79Q53432367-F81799E5-CF7D-4F58-87ED-0AD2623F357BQ55104056-9BAB51A2-2263-4538-8FE5-4A3C5013443B
P2860
Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Skin and subcutaneous adipose ...... needle length recommendations.
@en
Skin and subcutaneous adipose ...... needle length recommendations.
@nl
type
label
Skin and subcutaneous adipose ...... needle length recommendations.
@en
Skin and subcutaneous adipose ...... needle length recommendations.
@nl
prefLabel
Skin and subcutaneous adipose ...... needle length recommendations.
@en
Skin and subcutaneous adipose ...... needle length recommendations.
@nl
P2093
P1476
Skin and subcutaneous adipose ...... needle length recommendations.
@en
P2093
Christina H Arce
Karen J Byron
Laurence J Hirsch
Michael A Gibney
P304
P356
10.1185/03007995.2010.481203
P407
P577
2010-06-01T00:00:00Z